Ratner Management
About Ratner Management
Ratner Management is a family‑owned investment firm with roots dating back to the 1920s. The firm manages diversified investments including real estate acquisition and development on the West Coast, with a long‑term, hold‑it‑and‑develop‑it philosophy. Its history also includes venture capital activity and involvement in athletic branding and sports ventures, notably Major League Baseball affiliations, reflecting a broad, multi‑sector investment approach anchored in San Diego and the broader West Coast region.
Recent News
Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
Terremoto Wins $108m in Series C to Drive Cancer and Rare Disease Programmes
RA Capital Banks $75M for a Biotech SPAC
RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance
Apeiron Labs Closes $9.5 Million Series A
Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable Biologics
The Week’s 10 Biggest Funding Rounds: XAI Leads As 2026 Is Off To A Brisk Start
RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance
Avalanche Energy Nabs $29M
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
CellCentric Initiates DOMMINO-1, a Pivotal Phase 2 Clinical Trial of Inobrodib in Combination with Pomalidomide and Dexamethasone (InoPd) in Relapsed or Refractory Multiple Myeloma
InsideArbitrage Event Driven Monitor – April 1, 2026
Apeiron Labs Gets $9.5M to Flood the Oceans with Autonomous Underwater Robots
Terremoto Raises $108M to Pursue Development of Drugs Targeting AKT
Q32 Bio Raises $55M as Guardant, Soligenix, Novavax Lead Biotech Gains
Adcendo Raises $75M to Advance Cancer Drug Pipeline
Corxel Draws $287M Round to Drive Global Development of Oral GLP-1
Defense Watch: MQ-25 Taxiing, Harpoon Testing, Machina Raise, TNT Awards
Windward Bio Secures $165 Million to Accelerate Late‑Stage Asthma and COPD Trials
CellCentric Secures $220M in Europe’s Biggest Private Biotech Fundraise of 2026
The Week’s 10 Biggest Funding Rounds: Transportation And Biotech Take The Lead